Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

BIZARRE: Mei pharma s return on capital employed insights - You Need To See This

According to data from Benzinga Pro, during Q2, MEI Pharma's (NASDAQ:MEIP) reported sales totaled $18.22 million. Despite a 51.46% increase in earnings, the company posted a loss of $5.77 million. In Q1, MEI Pharma brought in $13.39 million in sales but lost $11.88 million in earnings.

Why Is ROCE Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.